4//SEC Filing
HANLY ANN M. 4
Accession 0001628280-24-006985
CIK 0001706431other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:34 PM ET
Size
9.5 KB
Accession
0001628280-24-006985
Insider Transaction Report
Form 4
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
- Sale
Common Stock
2024-02-22$10.05/sh−12,296$123,521→ 134,780 total - Award
Stock Option (Right to Buy)
2024-02-22+65,000→ 65,000 totalExercise: $10.11Exp: 2034-02-21→ Common Stock (65,000 underlying) - Award
Common Stock
2024-02-22+32,500→ 147,076 total
Holdings
- 11.52(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F3]The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.
- [F4]25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001854528
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:34 PM ET
- Size
- 9.5 KB